Background: Osborne-Mendel (OM) rats are prone to obesity when fed a high-fat diet, whereas S5B/Pl (S5B) rats are resistant to diet-induced obesity when fed the same diet. OM rats have a decreased satiation response to fatty acids infused in the gastrointestinal tract, compared to S5B rats. One possible explanation is that OM rats are less sensitive to the satiating hormone, glucagon-like peptide 1 (GLP-1). GLP-1 is produced in the small intestine and is released in response to a meal. The current experiments examined the role of GLP-1 in OM and S5B rats. Methods: Experiment 1 examined preproglucagon mRNA expression in the ileum of OM and S5B rats fed a high-fat (55% kcal) or low-fat (10% kcal) diet. Experiment 2 investigated the effects of a 2 h high-fat meal after a 24 h fast in OM and S5B rats on circulating GLP-1 (active) levels. Experiment 3 examined the effects of exendin-4 (GLP-1 receptor agonist) administration on the intake of a high-fat or a low-fat diet in OM and S5B rats. Results: Preproglucagon mRNA levels were increased in the ileum of OM rats compared to S5B rats and were increased by highfat diet in OM and S5B rats. OM and S5B rats exhibited a similar meal-initiated increase in circulating GLP-1 (active) levels. Exendin-4 dose dependently decreased food intake to a greater extent in S5B rats compared to OM rats. The intake of low-fat diet, compared to the intake of high-fat diet, was more sensitive to the effects of exendin-4 in these strains. Conclusions: These results suggest that though OM and S5B rats have similar preproglucagon mRNA expression in the ileum and circulating GLP-1 levels, OM rats are less sensitive to the satiating effects of GLP-1. Therefore, dysregulation of the GLP-1 system may be a mechanism through which OM rats overeat and gain weight.
Introduction
Osborne-Mendel (OM) and S5B/Pl (S5B) rats are established animal models used to examine individual differences in the response to dietary fat and mechanisms that lead to the overconsumption of dietary fat and subsequent obesity in animals that are prone to obesity. [1] [2] [3] [4] [5] [6] [7] [8] OM rats are more susceptible to diet-induced obesity and gain more weight and body fat when fed a high-fat diet than S5B rats, which are resistant to diet-induced obesity. Individual differences in the response to dietary fat between OM and S5B rats have been examined in a variety of paradigms; however, the response to dietary fat in the gastrointestinal (GI) tract is of particular interest because the GI tract produces hormonal signals that influence hunger and satiety. The response to nutrients in the GI tract has been examined in OM and S5B rats. Duodenal infusions of Intralipid and sodium linoleate on sham-fed animals (rats with a gastric cannula to drain gastric contents) suppressed food intake more completely and for a longer period of time in S5B rats compared to OM rats. 2 These data suggest that OM rats have a decreased satiation response to a high-fat diet and that differences in GI satiating mechanisms may contribute to the increased susceptibility to obesity in OM rats.
A number of GI hormones modulate food intake. Most of these GI hormones inhibit feeding (for example, cholecystokinin (CCK), glucagon-like peptide 1 (GLP-1), glucoseinsulin stimulating peptide, peptide YY and oxyntomodulin); only one, ghrelin, increases feeding. [9] [10] [11] [12] [13] [14] The effects of ghrelin have been investigated in OM and S5B rats. 4 Injection of growth hormone-releasing peptide-2, which binds to the same growth hormone secretagogue receptor as ghrelin had differential effects in OM and S5B rats. In satiated S5B rats, growth hormone releasing peptide-2 stimulated intake of low-fat diet, but not high-fat diet. In contrast, the satiated OM rats showed an increase in high-fat diet intake after growth hormone releasing peptide-2, with no effect on intake of low-fat diet. Thus, ghrelin may be an important component of the afferent signaling that differentiates these strains and their choice of a high-fat diet.
The inhibitory effects of CCK-8 on feeding behavior have also been examined in OM and S5B rats. 8 Though it was predicted that there would be a strain difference in the response to CCK-8, whose inhibitory effects on feeding are relayed to the brain by the vagus nerve, the inhibition of food intake by CCK-8 was similar in OM and S5B rats. 8 GLP-1 is one of several peptide hormones produced peripherally in the L cells of the small intestine, primarily in the distal small intestine (ileum) that induces satiation. 15, 16 GLP-1 levels are increased within minutes of consuming a meal, remain elevated for 3 h and provide a negative feedback signal to the brain, which leads to meal termination. GLP-1 is released in proportion to the caloric content of the meal. Studies suggest that circulating GLP-1 levels are lower after a meal in obese people than in lean controls. 12, [17] [18] [19] GLP-1 receptor agonists reduce blood glucose and food intake in rodents and chronic treatment with GLP-1 agonists results in loss of body weight. 20 GLP-1 receptors are expressed in a variety of peripheral tissues, including vagal afferent fibers 9, 15, [21] [22] [23] and in various regions of the brain, including the brain stem and hypothalamus. The anorectic effects of GLP-1 are preserved in obesity. 24 The current experiments were conducted to assess the role of GLP-1 on the intake of a high-fat diet in OM and S5B rats. In Experiment 1, the effect of either a high-fat or a low-fat diet on preproglucagon mRNA levels in the ileum of OM and S5B rats was investigated. It was hypothesized that preproglucagon mRNA levels would be increased after high-fat food intake in S5B rats, but not in OM rats. In Experiment 2, plasma levels of active GLP-1 from fed and fasted OM and S5B rats fed a high-fat diet were analyzed. It was hypothesized that OM rats would release less GLP-1 (active) after a high-fat meal, than S5B rats. In Experiment 3, exendin 4 (Ex-4), a GLP-1 receptor agonist, was administered to 24-h fasted OM and S5B rats fed either a high-fat or a low-fat diet. It was hypothesized that OM rats would be less sensitive to the satiating effects of Ex-4.
Methods

Animals
The 8-to 9-week-old male OM and S5B rats used in these studies were bred in Pennington Biomedical Research Center breeding colonies. Rats were individually housed in an AAALAC-approved animal facility on a 12:12 h light/dark cycle (lights on at 0700 hours) with food and water available. Animals were given access to a pelleted high-fat (55% kcal from fat)/low-carbohydrate (21% kcal from carbohydrate) diet or a pelleted low-fat (10% kcal from fat)/high carbohydrate (66% kcal from carbohydrate). [25] [26] [27] All procedures were approved by the Pennington Biomedical Research Center Institutional Animal Care and Use Committee. Experiment 1: real-time PCR analysis of preproglucagon mRNA levels in the ileum OM and S5B rats (8-9 weeks old) were fed either high-fat or low-fat diet for 2 weeks before kill (killed at 10-11 weeks of age). Food intake was measured daily, body weight was measured weekly and an index of body fat was determined at the time of kill by measurement of the retroperitoneal and epididymal fat pads ((fat pad weight (g)/body weight (g)) Â 100). For real-time PCR, we killed animals by decapitation. A 1-in. section of the ileum was removed, thoroughly cleaned and the enterocytes were removed by gentle scraping with a clean metal spatula. Excised enterocytes were immediately frozen on dry ice and stored at À80 1C until further processing.
Real-time PCR
RNA was isolated from enterocytes using Tri-Reagent (Molecular Research Center, Cincinnati, OH, USA) and RNeasy Mini Kit procedures (Qiagen, Valencia, CA, USA) and based on previous experiments. 27 Briefly, enterocytes were homogenized in Tri-Reagent using a motorized tissue homogenizer, chloroform was added to the lysate and the mixture was centrifuged (12 000 g) in phase lock tubes to separate RNA. Ethanol (70%) was added to the upper aqueous phase, which was filtered by centrifugation (8000 g). After multiple washes, we subjected the samples to an elution step using RNAase-free water. Reverse transcription (RT) was conducted using the High-Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems, Foster City, CA, USA). For RT, we added 2.0 mg of RNA from each sample to random primers (10 Â ), dNTP (25 Â ), MultiScribe Reverse Transcriptase (50 U ml À1 ) and RT buffer (10 Â ) and incubated it in a thermal cycler (PTC-100; MJ Research Inc., Watertown, MA, USA) for 10 min at 27 1C, then for 120 min at 37 1C. TaqMan Gene Expression Assays (Applied Biosystems) were used to assess levels of preproglucagon and the housekeeping gene, 18 s. For real-time PCR, we added TaqMan Universal PCR Master Mix (Applied Biosystems), gene expression assay and RT product (10 ng) to a 384-well plate. The cycling parameters consisted of an initial 2 min incubation at 50 1C, followed by 10 min at 95 1C, then 15 s at 95 1C and a 1 min annealing/extension step at 60 1C (40 cycles). The quantity of preproglucagon mRNA levels was based on a standard curve and normalized to 18S levels (ABI Prism 7900 Sequence Detection System; Applied Biosystems).
Experiment 2: circulating GLP-1 (active) levels OM and S5B rats (8-9 weeks old) were fed a high-fat diet for 2 weeks before kill. All rats were subjected to a 24 h fast.
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At the end of the 24 h fast, half of the rats were given access to high-fat diet for 2 h. At the end of this 2 h period, rats (10-11 weeks old) were killed. Animals were extensively handled during this experiment to habituate them to the experimental procedures. At the time of kill, trunk blood was collected to ensure adequate amounts of plasma for future assays. DPP-IV inhibitor was added to each sample (10 ml DPP-IV inhibitor per 1 ml blood), and samples were placed on ice. Blood was centrifuged at 3000 r.p.m. for 10 min at 4 1C and plasma was removed from tubes and stored at À80 1C until processing. A GLP-1 (active (7-36) amide) enzyme-linked immunosorbent assay kit was used to assess plasma GLP-1 in this experiment (Linco Research, St Charles, MO, USA). The GLP-1 assay was conducted as described in the protocol provided with the enzyme-linked immunosorbent assay kit. Briefly, on day 1, plasma and buffer were added to the enzyme-linked immunosorbent assay plate and the plate was incubated overnight. On day 2, after a series of washes, detection conjugate and substrate were added to each well as described in the protocol and the plate was read on a fluorescence plate reader with an excitation/emission wavelength of 355 nm/460 nm. Individual values were determined from a standard curve based on standards provided by the manufacturer.
Experiment 3: Ex-4 administration on food intake OM and S5B rats (8-9 weeks old) were fed either the high-fat or the low-fat diet for 4 weeks before testing. During this period, all animals were habituated to periods of fasting, in which food was removed for 24 h. Animals were also habituated to intraperitoneal injection procedures and during habituation, received an intraperitoneal injection of saline 10 min before the return of food. Animals were tested using a Latin square design in which each rat received each dose of Ex-4. Injections were given every 6 days. Body weight measurements indicated that the rats were gaining weight between injections. This design was used to control for any carryover effects from the drug. Before testing, rats were subjected to a 24 h fast immediately before administration of varying doses of Ex-4 (1, 5 and 10 mg kg À1 ; Sigma-Aldrich, St Louis, MO, USA) or saline. All injections were administered by intraperitoneal injection. After 10 min of Ex-4 administration, fresh food (high fat or low fat) was returned to the rat. Food intake was measured at 1, 2, 4 and 24 h after refeeding. Rats were 15-16 weeks old at the end of the experiment.
Statistical analysis
In Experiment 1, a mixed analysis of variance (ANOVA) was conducted to assess differences in daily food intake (kcal) and weekly body weight changes (strain Â diet Â time). A between-subjects ANOVA (strain Â diet) was used to compare the index of body adiposity ((retroperitoneal þ epididymal fat pad weight (g)/body weight) Â 100) and preproglucagon mRNA levels in the enterocytes of the ileum in high-fat and low-fat fed OM and S5B rats. Bonferroni post hoc tests were used to assess differences between individual groups. In Experiment 2, GLP-1 values were based on a standard curve. Individual sample values were analyzed by a between-subjects ANOVA (strain Â nutritional status). In Experiment 3, high-fat food intake (kcal) and low-fat food intake (kcal) following Ex-4 administration were analyzed by a mixed ANOVA (time Â Ex-4 concentration Â strain). An additional mixed ANOVA was conducted for each strain (time Â Ex-4 concentration). Bonferroni post hoc tests were used to compare saline to each dose of Ex-4, when a significant main effect or interaction was detected.
A significance level of Po0.05 was used for all tests.
Results
Experiment 1: real-time PCR analysis of preproglucagon mRNA levels in the ileum Food intake was measured daily for 2 weeks before kill. A strain Â day Â diet interaction (F(13,442) ¼ 2.04, Po0.02, Figure 1 ) and strain Â diet interaction (F(1,34) ¼ 24.79, Po0.0001) were detected. Post hoc analyses revealed that OM rats consumed significantly more high-fat (kcal) than low-fat diet (kcal) throughout the experiment (Po0.05). S5B rats consumed significantly more high-fat than low-fat diet on most days (days 1, 2, 3, 4, 7, 9, 10, 11, 12 and 14; Po0.05).
OM rats consumed more high-fat diet than S5B rats throughout the experiment, except for days 1 and 14, whereas OM rats consumed more low-fat diet than S5B rats on days 1, 10 and 12 (Po0.05). Body weight was measured weekly before kill. OM rats ate more high-fat food (HF) than low-fat food (LF) throughout the 14 days. S5B rats ate more high-fat food (HF) than low-fat food (LF) on most days. OM rats consumed more high-fat diet than S5B rats from days 2 to 13. Data are expressed in kilocalories (kcal) and shown as mean ± s.e.m. *OM high-fat diet vs OM low-fat diet; # S5B high-fat diet vs S5B low-fat diet; (Po0.05).
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Change in body weight from pre-diet weight was calculated each week. Main effects for strain and diet for week 1 were detected (F(1,34) ¼ 82.31, Po0.0001; F(1,34) ¼ 43.90, Po0.0001, respectively; Figure 2a ) and a strain Â diet interaction was detected for week 2 (F(1,34) ¼ 20.28, Po0.0001). OM rats gained more body weight than S5B rats. OM rats consuming high-fat diet gained more weight than OM rats consuming low-fat diet, and S5B rats consuming high-fat diet gained more weight than S5B rats consuming low-fat diet (Po0.05). An index of body fat was determined at the time of kill by weighing the retroperitoneal and epididymal fat pads. A strain Â diet interaction was detected for body fat index in these animals (F(1,34) ¼ 21.95, Po0.0001; see Figure 2b ). Post hoc tests revealed that OM rats had a higher index of body fat than S5B rats, and OM rats consuming a high-fat diet had a higher index of body fat than OM rats consuming a low-fat diet (Po0.05).
Preproglucagon mRNA levels were measured in ileal enterocytes of OM and S5B rats after 2 weeks access to either a high-fat or a low-fat diet. A between-subjects ANOVA revealed a main effect for strain (F(1,35) ¼ 16.07, Po0.0005; Figure 3 ). Post hoc analyses indicated significantly higher levels of preproglucagon mRNA in the ileal enterocytes of OM rats fed a low-fat diet compared to S5B rats fed a low-fat diet (Po0.05). In addition, the consumption of a high-fat diet increased preproglucagon mRNA levels in both OM and S5B rats (Po0.05). There was a 20.5 ± 0.15% vs 93.3 ± 0.25% (mean ± s.e.m.) increase in preproglucagon mRNA levels in high-fat fed OM and S5B rats compared to low-fat fed OM and S5B rats, respectively (t(17) ¼ 2.39, Po0.05).
Experiment 2: circulating GLP-1 (active) levels
Circulating active GLP-1 levels in OM and S5B rats were measured after either a 24 h fast or a 24 h fast followed by 2 h access to a high-fat diet. As expected, a significant main effect was detected for nutritional status (F(1,13) ¼ 18.5, Po0.001; Figure 4 ). Post hoc analyses revealed that refeeding for 2 h with a high-fat diet increased circulating active GLP-1 levels in OM and S5B rats (Po0.05). No differences were detected between the response to the high-fat meal in OM and S5B rats.
Experiment 3: Ex-4 administration on food intake
Food intake was measured after Ex-4 administration in OM and S5B rats fed either a high-fat or a low-fat diet. Several significant interaction effects were detected between time after injection, dose of Ex-4 and rat strain (time Â Ex-4 Â strain, F(9,147) Obesity-prone rats and GLP-1 SD Primeaux et al Figure 5a ). In addition, post hoc analyses revealed decreases in low-fat food intake in obesity-prone OM rats at 5 and 10 mg kg À1 of Ex-4 (Po0.05; Figure 5b ) compared to salinetreated control OM rats at 1, 2 and 4 h. High-fat food intake was decreased in OM rats receiving 5 and 10 mg kg À1 Ex-4 at 1 h after administration and in OM rats receiving 10 mg kg À1 Ex-4 at 2 h after administration (Po0.05; see Figure 5b ). High-fat and low-fat food intake was also measured at 24 h after administration of Ex-4. S5B rats ate less low-fat diet at 24 h when administered 1, 5 and 10 mg kg À1 Ex-4 compared to saline. High-fat diet intake in S5B rats was reduced at 24 h after administration of 5 and 10 mg kg À1 Ex-4 (Figure 6a , Po0.05). Twenty-four hour intake of low-fat diet was decreased in OM rats after administration of 5 and 10 mg kg À1 Ex-4. However, in high-fat fed rats, only 10 mg kg À1 Ex-4 decreased high-fat food intake in OM rats compared to saline-injected controls (Figure 6b , Po0.05).
Discussion
OM rats are prone to diet-induced obesity, whereas S5B rats are resistant to diet-induced obesity. Therefore, these rat strains have been used to examine individual differences in the response to a high-fat diet. When given ad libitum access to a high-fat diet, OM rats consume more high-fat diet, gain more weight and gain more body adiposity than S5B rats. [1] [2] [3] [4] [5] [6] [7] [8] In the current experiments, we were particularly interested in the individual differences in the response to dietary fat by the GI tract in OM and S5B rats. Previous studies indicate that OM rats are less responsive to the satiating effects of intraduodenal infusions of sodium linoleate and Intralipid than S5B rats. 2 This suggests that the satiation response to fatty acids is blunted in obesity-prone OM rats. One possible mechanism mediating the decreased satiation response to fatty acids in OM rats is the hormone, GLP-1. The current experiments were conducted to assess the role of GLP-1 in the intake of a high-fat diet in an established animal model of obesity.
In Experiment 1, OM and S5B rats were fed either a highfat diet (55% kcal from fat) or a low-fat diet (10% kcal from fat) for 14 days. Daily food intake, weekly body weight and an index of body adiposity were assessed. As expected OM rats consumed more high-fat than low-fat diet, and OM rats consumed more high-fat diet than S5B rats (see Figure 1 ). OM rats given access to a high-fat diet were hyperphagic throughout the experiment. As shown in Figure 2a , OM rats fed the high-fat diet gained more weight than OM rats fed the low-fat diet (73.9±2.8 g vs 45.5±2.4 g, mean ± s.e.m., respectively). S5B rats fed the high-fat diet gained more weight than S5B rats fed the low-fat diet (40.0 ± 1.9 g vs 31.6±1.7 g, mean ± s.e.m., respectively). On the basis of our index of body fat, OM rats had level of body fat than S5B rats (see Figure 2b ), which was exaggerated by consumption of the high-fat diet. 
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Using real-time PCR, we measured preproglucagon mRNA levels in the ileum in OM and S5B rats fed the low-fat or high-fat diets. On the basis of the previous report 2 that OM rats exhibited a decreased satiety response to intraduodenal infusions of fatty acids, we expected preproglucagon mRNA levels to be similar or even lower in OM than S5B rats and that these two strains would exhibit a differential response to the high-fat diet. Our data suggest that preproglucagon mRNA levels in the ileal enterocytes were higher in OM rats compared to S5B rats and that high-fat diet increased preproglucagon mRNA expression in both OM and S5B rats (see Figure 3 ). The relative increase in preproglucagon expression in response to the high-fat diet differed between strains. S5B rats exhibited a greater increase in preproglucagon expression in response to high-fat diet (93.3±0.25%, mean ± s.e.m.) than OM rats (20.5 ± 0.15%, mean ± s.e.m.). One possible explanation for these results is that the precursor protein, preproglucagon, can be processed into several different biological peptides including, GLP-1, GLP-2, glucagon, glucose-dependent insulinotropic peptide, glicentin-related pancreatic peptide and glicentin, which is later cleaved into oxyntomodulin and glicentin-related pancreatic peptide. [28] [29] [30] The enzymes, prohormone convertase 1 and 2, cleave proglucagon into different products depending on the tissue. 31 In the pancreas, glucagon is the major product and in the brain and intestine, GLP-1, GLP-2 and oxyntomodulin are the major products. 32 Therefore, our data suggest that the precursor for GLP-1, GLP-2 and oxyntomodulin is elevated in OM rats and is increased to differing degrees by a high-fat diet in OM and S5B rats. Experiment 2 was conducted to determine if circulating levels of GLP-1 differed between OM and S5B rats fed a high-fat diet and to determine if the meal-initiated release of GLP-1 differed between the two strains. GLP-1 levels are increased within minutes of consuming a meal, remain elevated for 3 h and provide a negative feedback signal to the brain, which leads to meal termination. Our data suggest that OM and S5B rats exhibit a similar meal-initiated increase in circulating GLP-1 after 2 h access to a high-fat diet (see Figure 4 ). Circulating GLP-1 binds to GLP-1 receptors in the central nervous system and the peripheral nervous system. 9, 15, [21] [22] [23] The data from Experiments 1 and 2 suggest that obesity-prone OM rats do not exhibit deficits in preproglucagon mRNA expression or in meal-initiated GLP-1 release, compared to obesity-resistant S5B rats. Therefore, it is possible that a dysregulation of central and peripheral GLP-1 receptors mediate the decreased satiation response to fatty acids that has been found in OM rats, compared to S5B rats. To begin to examine this possibility, we conducted Experiment 3.
In Experiment 3, Ex-4, a GLP-1 receptor agonist, was administered to 24 h fasted OM and S5B rats fed either a high-fat or a low-fat diet. It was hypothesized that OM rats would be less sensitive to the satiating effects of Ex-4. The data generated in Experiment 3 suggest that Ex-4 administration dose dependently decreased high-fat and low-fat food intake in fasted S5B rats for up to 24 h after administration (see Figure 5a ). As hypothesized, OM rats were less sensitive to the satiating effects of Ex-4 than S5B rats. Ex-4 administration transiently decreased high-fat food intake in fasted OM rats (see Figure 5b ). Unlike S5B rats, only the two highest doses of Ex-4 had any effect on either low-fat or high-fat food intake in OM rats. At the two highest doses of Ex-4, S5B rats had an almost complete suppression of food intake.
The current findings that obesity-prone OM rats exhibit higher levels of preproglucagon mRNA in the ileal enterocytes than S5B rats, exhibit a similar release of GLP-1 after a meal as S5B rats, but are less sensitive to the satiating effects of the GLP-1 receptor agonist, Ex-4, than S5B rats, suggest that dysregulation of GLP-1 receptors may mediate the decreased satiation response to fatty acids in OM rats. This decreased satiation response would then lead to the increased consumption of fatty acids/high-fat diets, which subsequently leads to obesity in obesity-prone OM rats. Therefore, deficits in GLP-1 signaling are likely a mechanism by which OM rats become obese and a mechanism that requires further investigation. Obesity-prone rats and GLP-1 SD Primeaux et al
